Overall, we believe that the novel dynamic findings discussed in this study will provide valuable insight into the mechanistic properties of G2019S LRRK2 and progress the field toward novel targeted disease-modifying therapies for PD. This evidence concerns the gene LRRK2 and Parkinson disease.